title: Aeroallergen-induced immediate asthmatic responses and late-phase associated pulmonary eosinophilia in the guinea pig: effect of methylprednisolone and mepyramine.
abstract: Guinea pigs were sensitized by intraperitoneal injection of ovalbumin, 10 micrograms mixed with 100 mg A1(OH)3 in saline. On days 15-30 sensitized guinea pigs were challenged with ovalbumin aerosol (0.5 mg/ml, 30 s, 15 psi) which produced immediate asthmatic responses characterized by dyspnea, convulsions, and some deaths during the first 14 min. Twenty to 24 h later the animals were sacrificed with an overdose of pentobarbital, and lungs, bronchi, and lower trachea were dissected and fixed in 10% neutral buffered formalin. Histopathological examination of randomly coded tissues of the respiratory tract revealed a pulmonary eosinophilic cellular infiltrate in the epithelium/subepithelium of trachea, bronchi, and bronchioles as well as the peribronchial, peribronchiolar, and perivascular areas of the lungs. Oral administration of mepyramine (10 mg/kg) 2 h before aeroallergen challenge provided complete protection against immediate asthmatic responses and prevented deaths during the first 14 min without influencing the late phase associated lung eosinophilic cellular infiltrate. The immediate asthmatic responses were not influenced by methylprednisolone (30 mg/kg) administered orally 24 and 2 h before aeroallergen challenge. Following an additional dose of methylprednisolone 4 h after challenge, there was a significant inhibition of pulmonary eosinophilia (30 mg/kg; -24 h, -2 h, and +4 h). These observations suggest that histamine is the principal mediator of immediate asthma attacks in guinea pigs. Methylprednisolone may be acting by inhibiting the production of eosinophil chemotactic factor of anaphylaxis (platelet-activating factor or leukotriene B4) from the alveolar macrophages, T lymphocytes, and perhaps other cells, thus preventing pulmonary eosinophilia.
authors.affiliation: Wallace Laboratories, Division of Carter-Wallace, Inc., Cranbury, N.J.
authors.forename: N
authors.initials: N
authors.lastname: Chand
authors.forename: F G
authors.initials: FG
authors.lastname: Hess
authors.forename: K
authors.initials: K
authors.lastname: Nolan
authors.forename: W
authors.initials: W
authors.lastname: Diamantis
authors.forename: J
authors.initials: J
authors.lastname: McGee
authors.forename: R D
authors.initials: RD
authors.lastname: Sofia
mesh_terms: D000284:Administration, Oral; D000336:Aerosols; D000631:Aminopyridines / Q000494:pharmacology*; D000818:Animals; D001249:Asthma / Q000517:prevention & control*; D004334:Drug Administration Schedule; D006168:Guinea Pigs; D008775:Methylprednisolone / Q000008:administration & dosage / Q000494:pharmacology*; D010047:Ovalbumin / Q000008:administration & dosage; D011292:Premedication; D011657:Pulmonary Eosinophilia / Q000473:pathology / Q000517:prevention & control*; D011738:Pyrilamine / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D000336:Aerosols; D000631:Aminopyridines; D010047:Ovalbumin; D011738:Pyrilamine; D008775:Methylprednisolone